Skip to main content
SpringerLink
Log in

Treatment of recurrent metastatic medulloblastoma with intensive chemotherapy and allogeneic bone marrow transplantation

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

We report here the first known case of a patient with recurrent metastatic medulloblastoma to achieve long-term disease-free survival following treatment with allogeneic bone marrow transplantation. A 27 year old white male with recurrent metastatic medulloblastoma involving lymph nodes, bone and bone marrow was treated with multi-agent chemotherapy followed by allogeneic bone marrow transplantation from an HLA-identical sibling donor. Morbidity was acceptable with moderate to severe mucositis in the immediate post transplant period and clinical grade I graft versus host disease of the skin controlled with modest doses of corticosteroids. The patient continues in unmaintained complete remission in excess of 28 months with a performance status of 100%. Allogeneic marrow transplantation following cytoreductive salvage chemotherapy is an aggressive strategy that may offer an improved likelihood of disease eradication and ultimate cure for poor prognosis patients with recurrent metastatic medulloblastoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hubbard JL, Scheithauer BU, Kispert DB, Carpenter SM, Wick MR, Laws ER: Adult cerebellar medulloblastomas: the pathological, radiographic, and clinical disease spectrum. J Neurosurg 70: 536–544, 1989

    Google Scholar 

  2. Garton GR, Schomberg PJ, Scheithauer BW, Shaw EG, Ilstrup DM, Blackwell CR, Laws ER, Earle JD: Medulloblastoma-prognostic factor's and outcome of treatment: review of the Mayo Clinic Experience. May Clinic Proc 65: 1077–1086, 1990

    Google Scholar 

  3. Levin VA, Sheline GE, Gutin PH: Neoplasms of the Central Nervous System. In: DeVita VT, Hellman, Rosenberg SA (eds) Cancer: Principles and Practice of Oncology. J.B. Lippincott CO. Philadelphia 1596, 1990

    Google Scholar 

  4. Rosenstock JG, Evans AE, Schut L: Response to vincristine of recurrent brain tumors in children. J Neurosurg 45: 135–140, 1976

    Google Scholar 

  5. Cangir A, van Eys J, Berry DH, Hvizdala E, Morgon SK: Combination chemotherapy with MOPP in children with recurrent brain tumors. Med Ped Oncol 4: 253–261, 1978

    Google Scholar 

  6. Crafts DC, Levin VA, Edwards MS, Pischer TL, Wilson CB: Chemotherapy of recurrent medulloblastoma with combined procarbazine, CCNU, and vineristine. J Neurosurg 49: 589–592, 1978

    Google Scholar 

  7. Allen JC, Helson L: High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children. J Neurosurg 555–749, 1981

  8. Kahn AB, D'Souza BJ, Wharam MD, Champion LAA, Sinks LF, Woo SY, McCullough DC, Leventhal BG: Cisplatinum therapy in recurrent childhood brain tumors. Cancer Treat Rep 66: 2013–2020, 1982

    Google Scholar 

  9. Levin VA, Vestnys PS, Edwards MS, Wara WM, Fulton D, Barger G, Seager M, Wilson CB: Improvement in survival produced by sequential therapies in the treatment of recurrent medulloblastomas. Cancer 51: 1364–1370, 1983

    Google Scholar 

  10. Feun LG, Savaraj N, Ozarda AT: Cisplatinum in medulloblastoma with extracranial metastasis: a case report. Cancer Treat Rep 68: 1307, 1984

    Google Scholar 

  11. Sexauer CL, Khan A, Burger PC, Krischer JP, Van Eys J, Vats T, Ragab AH: Cisplatinum in recurrent pediatric brain tumors: a POG Phase It study. Cancer 56: 1497–1501, 1985

    Google Scholar 

  12. Allen JC, Walker R, Luks E, Jennings M, Barfoot S, Tan C: Carboplatin and recurrent childhood brain tumors. J Clin Oncol 5: 459–463, 1987

    Google Scholar 

  13. Walker RW, Allen JC: Cisplatin in the treatment of recurrent childhood primary brain tumors. J Clin Oncol 6: 62–66, 1988

    Google Scholar 

  14. Friedman HS, Schold SC, Mahaley MS, Colvin OM, Oakes WJ, Vick NJ, Burger PC, Bigner SH, Borowitz M, Halperin EC, Djang W, Falletta JM, Delong R, Garvin JH, DeVivo DC, Norris D, Golembe B, Winter J, Bodziner RA, Sipahi H, Bigner DD: Phase II treatment of medulloblastoma and pineoblastoma with melphalan: clinical therapy based on experimental models of human medulloblastoma. J Clin Oncol 7: 904–911, 1989

    Google Scholar 

  15. Freidman HS, Colvin OM, Skapek SX, Ludemon SM, Elison GB, Schold SC, Jacobsen PF, Mohlbaier LH, Bigner DD: Experimental chemotherapy of human medulloblastoma cell lines and transplantable xenografts with bifunctional alkylating agents. Cancer Research 48: 4189–4195, 1988

    Google Scholar 

  16. Rosenfeld CS, Schwinghammer T, Przepinka D, Shadduck RK: A Phase II study of high-dose bulsulfan and VP-16 as a preparative regimen for autologus bone marrow transplantation for lymphoma. (Abstract) Blood 72 (suppl): 404A, 1988

  17. Vaughan WP, Martin JK, Arneson M, Garrey J, Coccia P, Klassen LW, Armitage JO: High-dose busulfan cyclophosphamide, VP-16, (BuCyVP) with allogeneic bone marrow transplantation (BMT) for marrow malignancy at high risk for relapse. (Abstract) Blood 72 (Suppl): 412A, 1988

  18. Spitzer TR, Cottler-Fox M, Cahill R, Greenspan A, Torrisi J, Deeg HJ: Escalating doses of VP-16 with cyclophosphamide and fractionating total body irradiation or busulfan as conditioning for bone marrow transplantation. (Abstract) Blood 72 (Suppl): 409A, 1988

  19. Tirelli U, D'Incalci M, Canetta R, Tumolo S, Franchin G, Veronesi A, Galligioni E, Trovo MG, Rossi C, Grigoletto E: Etoposide (VP-16–213) in malignant brain tumors: a Phase II study. J Clin Oncol 5: 432–437, 1984

    Google Scholar 

  20. Tutschka PJ, Copelan EA, Klein JP: Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood 70: 1382–1388, 1987

    Google Scholar 

  21. Antman K, Gale RP: Advanced breast cancer: high-dose chemotherapy and bone marrow autotransplants. Ann Int Med 108: 570–574, 1988

    Google Scholar 

  22. Frei E III, Antman K, Teicher B, Eder P, Schnipper L: Bone marrow autotransplantation for solid tumor-prospects. J Clin Oncol 7: 515–526, 1989

    Google Scholar 

  23. Friedman HS, Mahaley MS, Schold SC, Vick N, Falletta JM, Bullard DE, D'Souza BJ, Khandekar JB, Lew S, Oakes WJ, Bigner DD: Efficacy of vincristine and cyclophosphamide in the therapy of recurrent medulloblastoma. Neurosurg 18: 335–340, 1986

    Google Scholar 

  24. Pompili A: High dose polychemotherapy with autologous bone marrow transplantation in recurrent medulloblastoma —a piolot study. In: Walker MD, Thomas DGT (eds) Biology of Brain Tumor, Martinus-Nijhoff Publ. Netherlands 465–468, 1986

    Google Scholar 

  25. Nademanee AP, Forman ST, Schmidt GM, Bierman PJ, Snyder DS, O'Donnell MR, Lipsett JA, Blume KG: Allogeneic bone marrow transplantation for high-risk non Hodgkin's lymphoma during first complete remission. Blut 55: 11–13, 1987

    Google Scholar 

  26. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb H-J, Rimm AJ, Ringden O, Rozman C, Speck B, Truitt R, Zwann FE, Bortin ME. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75: 555–562, 1990

    Google Scholar 

  27. Truitt RL, LeFever AV, Shi CC-Y, Jeske JM, Martin TM: Graft-versus-leukemia effect. In: Burakoff SJ, et al. (ed) Graft-versus-Host Disease: Immunology, Pathophysiology and Treatment, Vol 12, Marcell Dekker, Inc., New York 177–204, 1990

    Google Scholar 

  28. Jones RJ, Ambinder RF, Piantadosi S, Santos G: Evidence of a Graft-versus-Lymphoma effect associated with allogeneic bone marrow transplantation. Blood 77: 649–653, 1991

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Medicine, and the Bone Marrow Transplantation Program of the Medical College of Wisconsin, 53226, Milwaukee, Wisconsin, USA

    Joel H. Lundberg, David E. Weissman, Peter A. Beatty & Robert C. Ash

  2. Departments of Pediatrics and the Bone Marrow Transplantation Program of the Medical College of Wisconsin, 53226, Milwaukee, Wisconsin, USA

    Robert C. Ash

Authors
  1. Joel H. Lundberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David E. Weissman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter A. Beatty
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Robert C. Ash
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lundberg, J.H., Weissman, D.E., Beatty, P.A. et al. Treatment of recurrent metastatic medulloblastoma with intensive chemotherapy and allogeneic bone marrow transplantation. J Neuro-Oncol 13, 151–155 (1992). https://doi.org/10.1007/BF00172764

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00172764

Key words

Search

Navigation